The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
May 14th 2024
The FDA has extended the review period for palopegteriparatide in treatment of hyperparathyroidism in adult patients by 3 months to August 14, 2024.
Prevalence of Metabolic Syndrome Among Young Adults on the Rise
June 30th 2020Although the investigative team found the overall increase in prevalence did not meet statistical significance, there was a significant increase among young adults, and prevalence remained high for those at least 60 years old.